Discovery of SHR1653, a Highly Potent and Selective OTR Antagonist with Improved Blood–Brain Barrier Penetration

[Image: see text] The oxytocin receptor (OTR) plays a major role in the control of male sexual responses. Antagonists of the OTR have been reported to inhibit ejaculation in animal models and serve as a potential treatment for premature ejaculation (PE). Herein, we describe a novel scaffold featurin...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:ACS Med Chem Lett
Autors principals: Li, Xin, Zhang, Zhigao, Chen, Yang, Wan, Hong, Sun, Jiakang, Wang, Bin, Feng, Bingqiang, Hu, Bing, Shi, Xingxing, Feng, Jun, Zhang, Lei, He, Feng, Bai, Chang, Zhang, Lianshan, Tao, Weikang
Format: Artigo
Idioma:Inglês
Publicat: American Chemical Society 2019
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6580551/
https://ncbi.nlm.nih.gov/pubmed/31223461
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsmedchemlett.9b00186
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars